Form 4: Ingevity Corp CEO John C. Fortson Reports Stock Transactions
SEC Form 4 Filing
John C. Fortson, President and CEO of Ingevity Corp, reports the vesting of restricted stock units and associated tax withholding, along with the grant of new restricted stock units.
Summary
- On February 28, 2024, John C. Fortson, the President and CEO of Ingevity Corp, engaged in several transactions involving Ingevity's common stock.
- A total of 1,597 shares were withheld by the company to cover tax obligations related to the vesting of 2022 restricted stock units (RSUs).
- Additionally, 2,995 shares were withheld to cover tax obligations related to the vesting of 2023 RSUs.
- Fortson was also granted 35,344 RSUs and 15,107 RSUs which will vest in three equal installments on February 28 of 2025, 2026, and 2027.
- Following these transactions, Fortson directly owns 151,652 shares of Ingevity Corp common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The transactions are routine and expected as part of the executive compensation plan. The grant of new RSUs suggests confidence in the company's future performance.
Positives
- The grant of new RSUs to the CEO aligns his interests with the long-term performance of the company.
- The vesting of previous RSUs indicates that performance targets were likely met.
Future Outlook
The newly granted RSUs will vest in three equal installments on February 28, 2025, 2026, and 2027, incentivizing the CEO to drive long-term value creation.
Industry Context
Executive compensation through stock grants and RSUs is a common practice in publicly traded companies to align management's interests with those of shareholders. The vesting schedules are designed to incentivize long-term performance.
Comparison to Industry Standards
- Stock-based compensation for CEOs is a standard practice across various industries, including specialty chemicals.
- Companies like Ashland, Celanese, and Eastman Chemical also utilize RSUs and stock options as part of their executive compensation packages.
- The vesting schedules and grant sizes are typically benchmarked against peer companies to ensure competitiveness and alignment with performance goals.
Stakeholder Impact
- Shareholders are impacted by the alignment of the CEO's interests with the company's long-term performance.
- Employees may be indirectly impacted by the CEO's incentives to drive company success.
Key Dates
| Date | Description |
|---|---|
| 02/28/2024 | Date of stock transactions, including vesting of RSUs and grant of new RSUs. |
| 02/28/2025 | First vesting date for the newly granted RSUs. |
| 02/28/2026 | Second vesting date for the newly granted RSUs. |
| 02/28/2027 | Final vesting date for the newly granted RSUs. |
| 03/01/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.